Boston Scientific Pacemaker Recall 2025 Affects ACCOLADE, ALTRUA 2 and CRT-P Devices Worldwide
Boston Scientific recalled 4,841 pacemakers worldwide on 2025-08-20 after a software issue could prevent Safety Mode activation in ambulatory settings. The affected devices include ACCOLADE family pacemakers and VISIONIST and VALITUDE CRT-Ps. Patients and healthcare providers should stop using the device immediately and follow the recall instructions in the notification letter.
Quick Facts at a Glance
Recall Date
August 20, 2025
Hazard Level
HIGH
Brand
Boston Scientific
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL, ELDERLY, PREGNANT
Hazard Information
Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life (EL) pacemakers; and VISIONIST and VALITUDE cardiac resynchronization therapy pacemakers (CRT-Ps).
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Boston Scientific Corporation or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
Pacemakers are implanted devices that regulate heart rhythm. They are used in patients with bradycardia or heart rhythm disorders. The recall affects multiple Boston Scientific models intended for long-term rhythm management.
Why This Is Dangerous
The defect relates to software that enhances Safety Architecture. It could prevent initiating Safety Mode in an ambulatory setting when battery impedance is high, potentially compromising device safety features.
Industry Context
This recall is not described as part of a broader industry pattern.
Real-World Impact
Affected patients may require medical evaluation, device monitoring, or replacement. The recall could disrupt ongoing rhythm-management therapy and necessitate clinical scheduling.
Practical Guidance
How to identify if yours is affected
Compare your device identifiers to the GTINs and serial numbers listed in the recall notice: GTIN 00802526576492; GTIN 00802526559334; Serial numbers 705372, 100002, 100003-100021.
Check your device label, packaging, or the patient ID card provided by your clinician for GTIN and serial numbers.
Refer to the FDA enforcement page for the official list of affected devices.
Where to find product info
Identifiers are on device labeling and packaging. Serial numbers are usually recorded in the patient device record and recall communications.
What timeline to expect
Remedies and replacements may take weeks to months, depending on clinical needs and device availability.
If the manufacturer is unresponsive
Escalate with your clinician and request a formal recall remediation plan.
Contact FDA recall enforcement or your local regulator if you receive no action within an advised timeframe.
How to prevent similar issues
Verify device status during routine device checks.
Keep the recall letter and any communications for future reference.
Discuss with your clinician about monitoring plans or replacement options,
Documentation advice
Keep the recall notification, device identifiers, clinician communications, and any replacement or monitoring documentation.
Product Details
Product: Pacemaker; Brand: Boston Scientific; Model numbers/identifiers: S701 ALTRUA 2 SR SL Pacemaker; GTINs 00802526576492 and 00802526559334; Serial numbers 705372, 100002, 100003-100021; Distribution: Worldwide; Sold: Unknown; Price: Unknown; Quantity recalled: 4841 units.
Reported Incidents
No injuries or incidents have been reported.
Key Facts
4,841 units recalled
Affects ACCOLADE family pacemakers and VISIONIST/VALITUDE CRT-Ps
Hazard: software could prevent Safety Mode initiation due to high battery impedance
Boston Scientific is recalling 806 EndoVive Safety PEG Kits sold nationwide. The recall concerns BD ChloraPrep Triple Swabsticks with open or compromised seals that could compromise sterility or dry the antiseptic solution. Hospitals and patients should stop using the kits immediately and follow the manufacturer's recall instructions.
Boston Scientific recalled 150 units of its *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System on December 19, 2025. The recall follows increased reports of stent deployment and expansion issues, which could lead to serious medical interventions. Healthcare providers and patients must stop using the device immediately.
Boston Scientific recalled 557 units of the AXIOS Stent and Electrocautery-Enhanced Delivery System on December 19, 2025. Increased reports of stent deployment and expansion issues prompted this recall. The defect may require additional medical intervention to resolve deployment failures.
Boston Scientific recalled 59 AXIOS Stents on December 19, 2025. Increased reports of deployment and expansion issues pose serious risks during procedures. Users should stop using the devices immediately and follow recall instructions.
Boston Scientific recalled 39 AXIOS Stent and Electrocautery-Enhanced Delivery Systems on December 19, 2025. Reports indicated issues with stent deployment and expansion, potentially leading to additional surgical interventions. The recall affects units distributed worldwide, including the United States and several other countries.
Boston Scientific recalled 588 units of its *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System on December 19, 2025. The recall follows multiple reports of stent deployment and expansion issues, posing serious risks during medical procedures.
Boston Scientific recalled 266 units of the HOT AXIOS Stent on December 19, 2025. Reports indicated deployment and expansion problems, posing risks of prolonged procedures and additional surgical interventions. Consumers must stop using the device immediately and follow the manufacturer's instructions.
Boston Scientific recalled 21,000 Coyote Over-the-Wire PTA Balloon Dilation Catheters on December 3, 2025. The recall affects devices that may not properly inflate or deflate, posing a risk during medical procedures. Patients and healthcare providers should stop using these devices immediately and follow the recall instructions.